13F

TSHA TAYSHA GENE THERAPIES INC

2026Q1 · CUSIP 877619106 · Sector: Healthcare & Biotech

Fading · Price holds, watch
Holders
190
Δ holders QoQ
-4
Breadth percentile
Top 76%
Whale holders
105
Δ whales
0
Inst. holding value
$1.2B
New positions
35
Closed positions
39
Price momentum (1Q)
+18.9%
Put / Call
3/4

Breadth history (34 quarters)

2020Q4: Δ+6 · h=52 2021Q1: Δ-5 · h=47 2021Q2: Δ+2 · h=49 2021Q3: Δ+0 · h=49 2021Q4: Δ+16 · h=65 2022Q1: Δ+7 · h=72 2022Q2: Δ-12 · h=60 2022Q3: Δ-5 · h=55 2022Q4: Δ-2 · h=53 2023Q1: Δ-8 · h=45 2023Q2: Δ-5 · h=40 2023Q3: Δ+24 · h=64 2023Q4: Δ+24 · h=88 2024Q1: Δ+21 · h=109 2024Q2: Δ-1 · h=108 2024Q3: Δ+13 · h=121 2024Q4: Δ+9 · h=130 2025Q1: Δ-2 · h=128 2025Q2: Δ+22 · h=150 2025Q3: Δ+5 · h=155 2025Q4: Δ+39 · h=194 2026Q1: Δ-4 · h=190 2020Q4: holders=52 2021Q1: holders=47 2021Q2: holders=49 2021Q3: holders=49 2021Q4: holders=65 2022Q1: holders=72 2022Q2: holders=60 2022Q3: holders=55 2022Q4: holders=53 2023Q1: holders=45 2023Q2: holders=40 2023Q3: holders=64 2023Q4: holders=88 2024Q1: holders=109 2024Q2: holders=108 2024Q3: holders=121 2024Q4: holders=130 2025Q1: holders=128 2025Q2: holders=150 2025Q3: holders=155 2025Q4: holders=194 2026Q1: holders=190 -39 -19.5 +0 +19.5 +39 36120204 20Q421Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 14% +18.9%
2025Q2 Top 14% +41.0% +58.7%
2024Q1 Top 14% -27.5% -33.3%
2023Q3 Top 6% +36.9% +96.8%

Options Sentiment

Put holders
3
QoQ: 0
Call holders
4
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.38
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
+3.4%
Quarterly Revenue & EPS (4Y)
2023-03-31: $5M 2023-06-30: $2M 2023-09-30: $5M 2023-12-31: $4M 2024-03-31: $3M 2024-06-30: $1M 2024-09-30: $2M 2024-12-31: $2M 2025-03-31: $2M 2025-06-30: $2M 2025-09-30: $0M 2025-12-31: $5M 2026-03-31: $0M 2024-03-31: EPS -0.10 2024-06-30: EPS -0.09 2024-09-30: EPS -0.10 2024-12-31: EPS -0.07 2025-03-31: EPS -0.08 2025-06-30: EPS -0.09 2025-09-30: EPS -0.09 2025-12-31: EPS -0.08 2026-03-31: EPS -0.12 0M 3M 5M $M -0.13 -0.07 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)